Literature DB >> 6838191

Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents.

G A Denys, R C Jerris, J M Swenson, C Thornsberry.   

Abstract

Susceptibilities of 104 Propionibacterium acnes isolates to each of 22 antimicrobial agents was evaluated by broth microdilution. These isolates were susceptible to all of the test agents except metronidazole. N-Formimidoyl thienamycin, a penem coded Sch 29482, and penicillin ranked first, second, and third, respectively, in activity and were significantly more active than other penicillins, cephalosporins, tetracyclines, clindamycin, or chloramphenicol.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6838191      PMCID： PMC186050          DOI： 10.1128/AAC.23.2.335

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  [Anaerobic Corynebacterium infections].

Authors:  A R Prévot
Journal:  Laval Med       Date:  1968-04

2.  Susceptibility of Propionibacterium acnes to seventeen antibiotics.

Authors:  W L Wang; E D Everett; M Johnson; E Dean
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

3.  Susceptibility of anaerobic bacteria to Sch 29482.

Authors:  V L Sutter; Y Y Kwok; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

4.  Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species.

Authors:  U Hoeffler; H L Ko; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Transitional forms of Corynebacterium acnes in disease.

Authors:  C H Zierdt; P T Wertlake
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

6.  Propionibacterium acnes: pathogen in central nervous system shunt infection. Report of three cases including immune complex glomerulonephritis.

Authors:  B A Beeler; J G Crowder; J W Smith; A White
Journal:  Am J Med       Date:  1976-12       Impact factor: 4.965
  6 in total
  10 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.

Authors:  John K Crane; Donald W Hohman; Scott R Nodzo; Thomas R Duquin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  Septicemia caused by Propionibacterium granulosum in a compromised patient.

Authors:  C Branger; B Bruneau; P Goullet
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 6.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 7.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

8.  Efficacy of 2% metronidazole gel in moderate acne vulgaris.

Authors:  Effat Khodaeiani; Rohollah F Fouladi; Neda Yousefi; Mehdi Amirnia; Shahla Babaeinejad; Javad Shokri
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

9.  Genotypic and antimicrobial characterisation of Propionibacterium acnes isolates from surgically excised lumbar disc herniations.

Authors:  Jess Rollason; Andrew McDowell; Hanne B Albert; Emma Barnard; Tony Worthington; Anthony C Hilton; Ann Vernallis; Sheila Patrick; Tom Elliott; Peter Lambert
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

10.  Characteristics and Treatment Outcomes of Propionibacterium acnes Prosthetic Shoulder Infections in Adults.

Authors:  Damani A Piggott; Yvonne M Higgins; Michael T Melia; Brandon Ellis; Karen C Carroll; Edward G McFarland; Paul G Auwaerter
Journal:  Open Forum Infect Dis       Date:  2015-12-09       Impact factor: 3.835
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.